| (210) | Number of the EPO application | 17712725 |
| (220) | Filing date of the EPO application | 2017.03.16 |
| (80) | EPO patent specification publication (B) | EPB nr. 34/2023, 2023.08.23 |
| (110) | EPO patent number | 3430045 |
| (21) | Number of the application | e 2019 0104 |
| (71) | Name(s) of applicant(s), code of the country | TILLOTTS PHARMA AG, CH; |
| (72) | Name(s) of inventor(s), code of the country | GUNDE Tea, CH;
MEYER Sebastian, CH;
FURRER Esther Maria, CH; |
| (73) | Name(s) of owner(s), code of the country | TILLOTTS PHARMA AG, CH; |
| (54) | Title of the invention | ANTI-TNFALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07K 16/24 (2006.01.01); A61P 1/00 (2006.01.01) |
| (19) | Country | CH |
| (41) | Date of publication of the application | 2019.02.28 |
| (30) | Priority | 16160918, 2016.03.17, EP |
| (86) | International application | PCT/EP2017/056246, 2017.03.16 |
| (87) | International publication | WO 2017/158097, 2017.09.21 |